Healthcare and Life Sciences Predictions 2020
Taxing times ahead
Tax is a hot topic right now for big business and will have major repercussions for the healthcare and life sciences industry. This paper explores the key tax challenges facing the industry and provides thought-provoking ideas to enable you to discuss future scenarios and how best to respond.
Pharma and the connected patient
How digital technology is enabling patient centricity
With over 260,000 health apps worldwide and 70% of patient groups using at least one app...
New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.
Identification of Medicinal Products
Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?
Measuring the return from pharmaceutical innovation 2015
Transforming R&D returns in uncertain times
Macroeconomic pressures have hit the R&D returns of life sciences firms, according to new Deloitte research. Our sixth annual pharmaceutical innovation study looks at the challenges the industry faces in generating returns from its R&D investments, while highlighting lessons that can be learned.